Multidisciplinary care of the patient with chronic obstructive pulmonary disease.

A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease. Nutr J (2011) 0.88

Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis (2011) 0.86

Determination of exacerbation predictors in patients with COPD in physical therapy - a longitudinal study. Braz J Phys Ther (2014) 0.75

Evaluating Comparative Effectiveness Research Priorities for Care Coordination in Chronic Obstructive Pulmonary Disease: A Community-Based eDelphi Study. JMIR Res Protoc (2015) 0.75

Clinical vocabulary as a boundary object in multidisciplinary care management of multiple chemical sensitivity, a complex and chronic condition. J Multidiscip Healthc (2011) 0.75

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA (2006) 10.54

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med (2003) 10.40

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA (2006) 10.31

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med (2003) 6.82

Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49

Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.09

Factors associated with medication nonadherence in patients with COPD. Chest (2005) 2.24

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09

Pill taking 'routinization': a critical factor to understanding episodic medication adherence. AIDS Care (2003) 1.77

Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67

Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol (1998) 1.63

Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61

Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J (2002) 1.60

Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med (2003) 1.56

A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Am J Med (1998) 1.53

The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest (2006) 1.46

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics (1992) 1.33

Medication adherence patterns in chronic obstructive pulmonary disease. Chest (1991) 1.30

Nutritional support for individuals with COPD: a meta-analysis. Chest (2000) 1.16

COPD: exacerbation. Chest (2000) 0.90

Compliance with aerosol therapy in chronic obstructive lung disease. N Z Med J (1981) 0.89

Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl (2003) 0.89

[The value of physical therapy with VRP 1-Desitin ("Flutter")]. Pneumologie (1992) 0.88

Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2001) 0.87

Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis. Monaldi Arch Chest Dis (1995) 0.85

First-line pharmacotherapy for tobacco use and dependence. J Am Board Fam Pract (2002) 0.81

Psychological changes in exercising COPD patients. Int J Rehabil Res (1988) 0.77

[Comorbidities of COPD]. Internist (Berl) (2006) 0.77

Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial. COPD (2012) 1.59

Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest (2004) 1.16

Lung volume reduction surgery using the NETT selection criteria. Ann Thorac Surg (2011) 0.86

The effect of pulmonary rehabilitation on healthcare utilization in chronic obstructive pulmonary disease: The Northeast Pulmonary Rehabilitation Consortium. J Cardiopulm Rehabil (2006) 0.86

Gemcitabine-induced pulmonary toxicity. Anticancer Res (2012) 0.86

Exercise ventilatory kinematics in endurance trained and untrained men and women. Respir Physiol Neurobiol (2011) 0.77

NETT coordinators: researchers, caregivers, or both? Proc Am Thorac Soc (2008) 0.75